These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 14711082)
1. Pharmacodynamics and clinical use of anti-HIV drugs. Preston SL; Piliero PJ; Drusano GL Infect Dis Clin North Am; 2003 Sep; 17(3):651-74. PubMed ID: 14711082 [TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring in HIV infection: current status and future directions. Back D; Gatti G; Fletcher C; Garaffo R; Haubrich R; Hoetelmans R; Kurowski M; Luber A; Merry C; Perno CF AIDS; 2002 Mar; 16 Suppl 1():S5-37. PubMed ID: 12035820 [TBL] [Abstract][Full Text] [Related]
4. Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors. Huisman MT; Smit JW; Schinkel AH AIDS; 2000 Feb; 14(3):237-42. PubMed ID: 10716499 [No Abstract] [Full Text] [Related]
5. Therapeutic management of HIV. Johnson D Oral Dis; 2002; 8 Suppl 2():17-20. PubMed ID: 12164653 [TBL] [Abstract][Full Text] [Related]
6. The ups and downs of drug levels: a PK primer. Munk B GMHC Treat Issues; 2001; 15(7-8):8-11. PubMed ID: 11548511 [No Abstract] [Full Text] [Related]
7. Intracellular pharmacology of nucleoside analogues and protease inhibitors: role of transporter molecules. Hoggard PG; Back DJ Curr Opin Infect Dis; 2002 Feb; 15(1):3-8. PubMed ID: 11964899 [TBL] [Abstract][Full Text] [Related]
8. Simplifying drug regimens. HIV Hotline; 1998 Mar; 8(1):11. PubMed ID: 11365353 [TBL] [Abstract][Full Text] [Related]
9. Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy. Lima VD; Gill VS; Yip B; Hogg RS; Montaner JS; Harrigan PR J Infect Dis; 2008 Jul; 198(1):51-8. PubMed ID: 18498238 [TBL] [Abstract][Full Text] [Related]
10. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. Yeni PG; Hammer SM; Carpenter CC; Cooper DA; Fischl MA; Gatell JM; Gazzard BG; Hirsch MS; Jacobsen DM; Katzenstein DA; Montaner JS; Richman DD; Saag MS; Schechter M; Schooley RT; Thompson MA; Vella S; Volberding PA JAMA; 2002 Jul; 288(2):222-35. PubMed ID: 12095387 [TBL] [Abstract][Full Text] [Related]
11. Once-daily administration of antiretrovirals: pharmacokinetics of emerging therapies. Taburet AM; Paci-Bonaventure S; Peytavin G; Molina JM Clin Pharmacokinet; 2003; 42(14):1179-91. PubMed ID: 14606928 [TBL] [Abstract][Full Text] [Related]
12. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections]. Pozio E Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs? Aarnoutse RE; Schapiro JM; Boucher CA; Hekster YA; Burger DM Drugs; 2003; 63(8):741-53. PubMed ID: 12662123 [TBL] [Abstract][Full Text] [Related]
14. Saquinavir: a review of its use in boosted regimens for treating HIV infection. Plosker GL; Scott LJ Drugs; 2003; 63(12):1299-324. PubMed ID: 12790697 [TBL] [Abstract][Full Text] [Related]